PCI Biotech Holding
Develops light-activated drug delivery for cancer, dermatology, and gene therapy manufacturing.
PCIB | OL
Overview
Corporate Details
- ISIN(s):
- NO0010405640
- LEI:
- 5967007LIEEXZXFIGG77
- Country:
- Norway
- Address:
- Ullernchausséen 64, 0379 OSLO
- Website:
- https://www.pcibiotech.no/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
PCI Biotech Holding is a biopharmaceutical company developing therapeutic products based on its proprietary Photochemical Internalisation (PCI) technology. This platform is designed to enable the efficient intracellular delivery of therapeutic molecules. The company's development programs are focused on several areas, including immunotherapy and dermatology, with the photosensitiser fimaporfin (Amphinex) as a key product candidate for cancer treatment. Additionally, PCI Biotech applies its technology to bioprocessing, aiming to advance and improve the manufacturing of viral vectors for gene therapies. The technology originated from research at the Oslo Radium Hospital.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for PCI Biotech Holding and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-26 16:14 |
Report Publication Announcement
PCI Biotech: Invitation to first half 2025 results presentation and corporate u…
|
English | 2.3 KB | |
| 2025-08-22 14:15 |
Major Shareholding Notification
Flaggemelding
|
Norwegian | 411 bytes | |
| 2025-08-22 11:09 |
Major Shareholding Notification
Flaggemelding
|
Norwegian | 451 bytes | |
| 2025-08-18 20:39 |
Regulatory News Service
PCI Biotech announces discontinuation of development of the PCL technology and …
|
English | 3.4 KB | |
| 2025-05-22 09:45 |
Post-Annual General Meeting Information
PCI Biotech: Minutes of Annual General Meeting 2025
|
Norwegian | 449.8 KB | |
| 2025-05-22 09:45 |
Post-Annual General Meeting Information
PCI Biotech: Minutes of Annual General Meeting 2025
|
English | 866 bytes | |
| 2025-05-20 20:08 |
Declaration of Voting Results & Voting Rights Announcements
PCI BIotech: Disclosure of voting rights for Chair of the Board
|
English | 1.2 KB | |
| 2025-04-30 08:00 |
Pre-Annual General Meeting Information
Notice of Annual General Meeting 2025
|
Norwegian | 188.6 KB | |
| 2025-04-30 08:00 |
Pre-Annual General Meeting Information
Notice of Annual General Meeting 2025
|
Norwegian | 146.9 KB | |
| 2025-04-30 08:00 |
Pre-Annual General Meeting Information
Notice of Annual General Meeting 2025
|
English | 167.8 KB | |
| 2025-04-30 08:00 |
Pre-Annual General Meeting Information
Notice of Annual General Meeting 2025
|
English | 208.0 KB | |
| 2025-04-30 08:00 |
Pre-Annual General Meeting Information
Notice of Annual General Meeting 2025
|
English | 977 bytes | |
| 2025-04-24 15:30 |
Annual Report (ESEF)
PCI Biotech Holding ASA: Annual Report 2024
|
English | 5.4 MB | |
| 2025-04-24 15:30 |
Annual Report
PCI Biotech Holding ASA: Annual Report 2024
|
English | 1.2 MB | |
| 2025-04-24 15:30 |
Report Publication Announcement
PCI Biotech Holding ASA: Annual Report 2024
|
English | 908 bytes |
Automate Your Workflow. Get a real-time feed of all PCI Biotech Holding filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for PCI Biotech Holding via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
